Familial gastrointestinal stromal tumor syndrome: Report of 2 cases with kit exon 11 mutation

Cancer Control

Volumn 22, Issue 1, 2015, Pages 102-108

  Jones, Derek H ^a   Caracciolo, Jamie T ^b   Hodul, Pamela J ^c   Strosberg, Jonathan R ^c   Coppola, Domenico ^c   Bui, Marilyn M ^c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Diagnostic Imaging and Interventional Radiology   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; DOG1 PROTEIN; IMATINIB; KI 67 ANTIGEN; PROTEIN; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG; ANO1 PROTEIN, HUMAN; ANTINEOPLASTIC AGENT; BENZAMIDE DERIVATIVE; CD34 ANTIGEN; CHLORIDE CHANNEL; DESMIN; PIPERAZINE DERIVATIVE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN S 100; PYRIMIDINE DERIVATIVE; TUMOR PROTEIN;

ABDOMINAL PAIN; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CANCER MORPHOLOGY; CANCER REGRESSION; CASE REPORT; CHOLECYSTECTOMY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONVALESCENCE; DIAGNOSTIC IMAGING; EXON; FAMILIAL GASTROINTESTINAL STROMAL TUMOR SYNDROME; FEMALE; GASTRECTOMY; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL STROMAL TUMOR; GENE DELETION; GENE IDENTIFICATION; GENE MUTATION; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE RESECTION; MOLECULAR DIAGNOSIS; ONCOGENE C KIT; PARTIAL GASTRECTOMY; SPINDLE CELL CARCINOMA; STOMACH BIOPSY; TREATMENT OUTCOME; GASTROINTESTINAL STROMAL TUMORS; GENETICS; METABOLISM; RADIOGRAPHY; RETROSPECTIVE STUDY;

ADULT; ANTIGENS, CD34; ANTINEOPLASTIC AGENTS; BENZAMIDES; CHLORIDE CHANNELS; DESMIN; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; IMATINIB MESYLATE; NEOPLASM PROTEINS; PIPERAZINES; PROTO-ONCOGENE PROTEINS C-KIT; PYRIMIDINES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RETROSPECTIVE STUDIES; S100 PROTEINS;

EID: 84924767462     PISSN: 10732748     EISSN: 15262359     Source Type: Journal    
DOI: 10.1177/107327481502200113     Document Type: Article

References (29)

1. Burgoyne AM, Somaiah N, Sicklick JK. Gastrointestinal stromal tumors in the setting of multiple tumor syndromes. Curr Opin Oncol. 2014;26(4):408-414.
2. Fletcher BJ, Hogendoorn PCW, Mertens F. WHO Classification of Tumours of Soft Tissue and Bone. 4th ed. Lyon: IARC Press; 2013: 164-167.
3. Postow MA, Robson ME. Inherited gastrointestinal stromal tumor syndromes: mutations, clinical features, and therapeutic implications. Clin Sarcoma Res. 2012;2(1):16.
4. Neuhann TM, Mansmann V, Merkelbach-Bruse S, et al. A novel germ­line KIT mutation (p.L576P) in a family presenting with juvenile onset of multiple gastrointestinal stromal tumors, skin hyperpigmentations, and esophageal stenosis. Am J Surg Pathol. 2013;37(6):898-905.
5. Nakai M, Hashikura Y, Ohkouchi M, et al. Characterization of novel germline c-kit gene mutation, KIT-Tyr553Cys, observed in a family with multiple gastrointestinal stromal tumors. Lab Invest. 2012;92(3):451-457.
6. Peña-Irún A, Villa-Puente M, García-Espinosa R, et al. Familial gastro­intestinal stroma tumor due to mutation in exon 13 (K642E) of the KIT gene [In Spanish]. Med Clin (Barc). 2012;139(11):512-513.
7. Adela Avila S, Peñaloza J, González F, et al. Dysphagia, melanosis, gastrointestinal stromal tumors and a germinal mutation of the KIT gene in an Argentine family. Acta Gastroenterol Latinoam. 2014;44(1):9-15.
8. Yamanoi K, Higuchi K, Kishimoto H, et al. Multiple gastrointestinal stromal tumors with novel germline c-kit gene mutation, K642T, at exon 13. Hum Pathol. 2014;45(4):884-888.
9. Wadt K, Andersen MK, Hansen TV, et al. A new genetic diagno­sis of familiar gastrointestinal stromal tumour [In Danish]. Ugeskr Laeger. 2012;174(21):1462-1464.
10. Chompret A, Kannengiesser C, Barrois M, et al. PDGFRA germline mutation in a family with multiple cases of gastrointestinal stromal tumor. Gastroenterology. 2004;126(1):318-321.
11. de Raedt T, Cools J, Debiec-Rychter M, et al. Intestinal neurofibro­matosis is a subtype of familial GIST and results from a dominant activating mutation in PDGFRA. Gastroenterology. 2006;131(6):1907-1912.
12. Pasini B, Matyakhina L, Bei T, et al. Multiple gastrointestinal stromal and other tumors caused by platelet-derived growth factor receptor alpha gene mutations: a case associated with a germline V561D defect. J Clin Endocrinol Metab. 2007;92(9):3728-3732.
13. Corless CL, Barnett CM, Heinrich MC. Gastrointestinal stromal tumours: origin and molecular oncology. Nat Rev Cancer. 2011;11(12):865-878.
14. Huss S, Künstlinger H, Wardelmann E, et al. A subset of gastrointestinal stromal tumors previously regarded as wild-type tumors carries somatic acti­vating mutations in KIT exon 8 (p.D419del). Mod Pathol. 2013;26(7):1004-1012.
15. Gounder MM, Maki RG. Molecular basis for primary and secondary tyrosine kinase inhibitor resistance in gastrointestinal stromal tumor. Cancer Chemother Pharmacol. 2011;67(suppl 1):S25-S43.
16. Miettinen M, Lasota J. Gastrointestinal stromal tumors. Gastroenterol Clin North Am. 2013;42(2):399-415.
17. Hubbard SR. Juxtamembrane autoinhibition in receptor tyrosine kinas­es. Nat Rev Mol Cell Biol. 2004;5(6):464-471.
18. Tarn C, Merkel E, Canutescu AA, et al. Analysis of KIT mutations in sporadic and familial gastrointestinal stromal tumors: therapeutic implications through protein modeling. Clin Cancer Res. 2005;11(10):3668-3677.
19. Lasota J, Miettinen M. A new familial GIST identified. Am J Surg Pathol. 2006;30(10):1342.
20. Kleinbaum EP, Lazar AJ, Tamborini E, et al. Clinical, histopathologic, molecular and therapeutic findings in a large kindred with gastrointestinal stromal tumor. Int J Cancer. 2008;122(3):711-718.
21. Nakahara M, Isozaki K, Hirota S, et al. A novel gain-of-function mu­tation of c-kit gene in gastrointestinal stromal tumors. Gastroenterology. 1998;115(5):1090-1095.
22. Lasota J, Miettinen M. Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours. Histopathology. 2008;53(3):245-266.
23. Emile JF, Théou N, Tabone S, et al. Clinicopathologic, phenotypic, and genotypic characteristics of gastrointestinal mesenchymal tumors. Clin Gastroenterol Hepatol. 2004;2(7):597-605.
24. Haller F, Schulten HJ, Armbrust T, et al. Multicentric sporadic gastro­intestinal stromal tumors (GISTs) of the stomach with distinct clonal origin: differential diagnosis to familial and syndromal GIST variants and peritoneal metastasis. Am J Surg Pathol. 2007;31(6):933-937.
25. Nilsson B, Bumming P, Meis-Kindblom JM, et al. Gastrointestinal stro­mal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era--a population-based study in western Sweden. Cancer. 2005;103(4):821-829.
26. Agaimy A, Dirnhofer S, Wünsch PH, et al. Multiple sporadic gastro­intestinal stromal tumors (GISTs) of the proximal stomach are caused by different somatic KIT mutations suggesting a field effect. Am J Surg Pathol. 2008;32(10):1553-1559.
27. Gasparotto D, Rossi S, Bearzi I, et al. Multiple primary sporadic gas­trointestinal stromal tumors in the adult: an underestimated entity. Clin Cancer Res. 2008;14(18):5715-5721.
28. von Mehren M, Randall RL, Benjamin RS, et al. Gastrointestinal stromal tumors, version 2.2014. J Natl Compr Canc Netw. 2014;12(6):853-862.
29. Nakagomi N, Hirota S. Juxtamembrane-type c-kit gene mutation found in aggressive systemic mastocytosis induces imatinib-resistant constitutive KIT activation. Lab Invest. 2007;87(4):365-371.